Intrinsic Value

The intrinsic value of Biolight Life Sciences Ltd (BOLT) under the Base Case is ILS per share. Compared with the current market price of 301.5 ILS, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

BOLT Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when BOLT is below its intrinsic value
Today Hidden ·
BOLT Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to BOLT

Fundamental Analysis

What Biolight Life Sciences Does

Life Sciences Tools & Services Health Care

BioLight Life Sciences Ltd. engages in the management, research and development, investments or sale of solutions, the purpose of which is to address a real need that exists in the field of eye diseases. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property.

Headquarters
Israel IL
IPO date
Dec 27, 2005
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue BOLT Research

Decided on Biolight Life Sciences? Get an email when BOLT reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one BOLT stock?

The intrinsic value for Biolight Life Sciences Ltd (BOLT) under the Base Case is ILS.

Is BOLT stock undervalued or overvalued?

Compared with the current market price of 301.5 ILS, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top